Relivion Alternatives

Relivion MG offers one approach to neuromodulation for migraine, but it requires a prescription and is described for acute treatment of migraine in adults. Migraine affects more than 1 billion people worldwide, and many people compare drug-free devices based on access, labeling, placement, treatment format, refill needs, and ongoing cost structure.

This guide reviews five Relivion alternatives, starting with Cefaly, an FDA-cleared external trigeminal nerve stimulation (e-TNS) device available without a prescription for acute treatment of migraine and prophylactic treatment of episodic migraine in adults.

Key Takeaways

• Prescription-free e-TNS access sets Cefaly apart: Cefaly is an FDA-cleared e-TNS device available without a prescription in the U.S., Canada, the EU, and other countries for acute treatment of migraine and prophylactic treatment of episodic migraine in adults.
• Relivion and Cefaly differ by FDA-cleared use: Relivion MG is described for acute migraine treatment in adults, while Cefaly offers an acute treatment mode and a preventive mode for episodic migraine in one device.
• Cost structures vary by device: Cefaly uses an ownership model with replacement electrodes, while some prescription devices use refill, prescription, or program-based access models.
• Cefaly clinical evidence supports e-TNS for migraine: Cefaly clinical studies report acute and preventive treatment outcomes, including pain reduction after acute treatment and reduced monthly migraine days with preventive use.
• Device placement differs across options: Alternatives include forehead-worn e-TNS, upper-arm remote electrical neuromodulation, neck-based vagus nerve stimulation, back-of-head transcranial magnetic stimulation, and forehead-worn preventive TENS formats.

Understanding Neuromodulation Devices for Migraine

Neuromodulation devices use electrical or magnetic stimulation to interact with nerve pathways involved in migraine. These devices are generally discussed as drug-free options because they do not add another medication to a migraine care routine.

The trigeminal nerve is the primary pathway for migraine pain. External trigeminal nerve stimulation devices such as Cefaly use an electrode positioned on the forehead, between and just above the eyebrows, to deliver gentle electrical impulses to branches of the trigeminal nerve.

When comparing Relivion alternatives, the main informational factors include:

• FDA-cleared use, such as acute treatment, preventive treatment, or both
• Prescription or over-the-counter access
• Age indication
• Device placement
• Session length and treatment format
• Refill, subscription, prescription, or ownership model
• App support, tracking tools, and user support resources

1. Cefaly

Best For: Adults comparing a prescription-free forehead e-TNS device for acute migraine treatment and episodic migraine prevention

Access: No prescription required

Treatment Format: Forehead-worn external trigeminal nerve stimulation device with Acute and Prevent modes

Cefaly is an FDA-cleared e-TNS device for acute migraine treatment and prophylactic treatment of episodic migraine in adults. It is placed on the forehead, between and just above the eyebrows, where it delivers gentle electrical stimulation to the trigeminal nerve pathway. For people comparing Relivion alternatives, Cefaly is especially relevant because it combines prescription-free access, acute and preventive treatment modes for adults with migraine, app support where available, HSA/FSA eligibility, coaching resources, and an ownership-based device model.

What Makes It Stand Out

Cefaly stands out for its combination of prescription-free access and dual treatment format. Its Acute mode is a 60-minute session for use during a migraine attack, while its Prevent mode is a 20-minute daily session for preventive use in episodic migraine. This creates a single-device format for people comparing acute and preventive neuromodulation options.

Cefaly also offers practical support features that are important for day-to-day use. The Cefaly Migraine Relief app can pair with compatible Cefaly devices for treatment tracking, session control, migraine logging, and wearable integrations with platforms such as Apple Health, Google Health, Fitbit, Oura, and Garmin. Cefaly also offers one-on-one coaching, HSA/FSA eligibility, financing options, and a refund-based 90-day satisfaction guarantee for eligible direct purchases fromthe official website.

Cefaly Clinical Evidence

Its clinical studies summarizes research across acute and preventive use, including 20+ years of research and 12 clinical trials.

In Cefaly’s acute-treatment evidence, the ACME study reported that 79% of patients experienced significant headache pain reduction after one hour of treatment, and 63% saw pain decrease by 50% or more.

In Cefaly’s preventive-treatment evidence, the PREMICE study reported a 32.7% decrease in monthly headache days after three months of compliant treatment, with 38.1% of patients achieving a 50% or greater reduction in migraine days.

These study results are specific to Cefaly and are not intended as a clinical-evidence comparison across migraine devices.

Cefaly Pricing and Access

Cefaly uses an ownership model. The device is purchased once, and replacement electrodes are the main recurring supply cost. The device is also listed as HSA/FSA eligible, which may help some users apply pre-tax healthcare funds depending on plan rules.

If a Cefaly device is purchased directly fromthe official website and the customer is not satisfied, Cefaly’s return policy states that eligible devices and products may be returned for a refund within 90 calendar days of the product delivery date.

Cefaly Compared With Relivion

Cefaly and Relivion differ in several practical ways. Cefaly is available without a prescription and is FDA-cleared for acute treatment of migraine and prophylactic treatment of episodic migraine in adults. Relivion MG requires a prescription and is described for acute migraine treatment in adults. Cefaly is worn on the forehead and targets the trigeminal nerve pathway through e-TNS, while Relivion uses a head-worn device format that stimulates trigeminal and occipital nerve branches.

2. Nerivio

Best For: People comparing an upper-arm device format and prescription-based access

Access: Prescription required

Treatment Format: Smartphone-controlled remote electrical neuromodulation device worn on the upper arm

Nerivio uses remote electrical neuromodulation through an upper-arm wearable. This format differs from forehead-based devices because the device is worn away from the head, which may be an important practical consideration for people comparing device placement during migraine attacks.

What Makes It Stand Out

Nerivio offers upper-arm placement, smartphone-controlled treatment, and an age indication that includes patients 8 years of age or older. Nerivio is indicated for acute and/or preventive treatment of migraine with or without aura and is described as a prescription-use, self-administered device for the home environment.

Nerivio also has a refill-based format. Current Nerivio support materials state that Nerivio models and Nerivio Infinity Refill Units are designed to provide 18 full 45-minute treatments, used as needed or as directed by the prescription.

3. gammaCore Sapphire

Best For: People comparing a neck-based device format and a prescription non-invasive vagus nerve stimulation option

Access: Prescription required

Treatment Format: Handheld non-invasive vagus nerve stimulation device applied to the side of the neck

gammaCore Sapphire uses non-invasive vagus nerve stimulation, also called nVNS. Instead of being placed on the forehead or upper arm, the device is applied to the side of the neck. This creates a different stimulation target and a different user experience from forehead-based e-TNS devices. 

What Makes It Stand Out

gammaCore stands out for its neck-based placement, handheld design, and FDA-cleared headache indications that include migraine and cluster headache uses. gammaCore materials describe preventive treatment of migraine headache and acute treatment of pain associated with migraine headache in adolescent patients age 12 and older and adults, along with cluster headache-related indications.

The device is available by prescription. Current pricing and coverage details can be confirmed through gammaCore or the relevant prescribing and access channel.

4. SAVI Dual

Best For: People comparing a magnetic stimulation device format and prescription-based access

Access: Prescription required

Treatment Format: Transcranial magnetic stimulation device positioned at the back of the head

SAVI Dual uses transcranial magnetic stimulation, often abbreviated as TMS or sTMS. This differs from electrical stimulation devices because it delivers magnetic pulses rather than electrical impulses. It is positioned at the back of the head and is described by eNeura as a prescription non-drug therapy for acute and prophylactic treatment of migraine headache in adolescents age 12 and older and adults.

What Makes It Stand Out

SAVI Dual stands out because it uses a different stimulation mechanism from e-TNS, REN, and nVNS devices. Its back-of-head placement and magnetic-pulse format may be relevant for people comparing device types, stimulation targets, and prescription access models.

5. HeadaTerm 2

Best For: People comparing an over-the-counter forehead device with preventive-use labeling

Access: Over-the-counter

Treatment Format: Forehead-worn transcutaneous electrical nerve stimulation device for migraine prophylaxis

HeadaTerm 2 is a forehead-worn transcutaneous electrical nerve stimulation device. FDA 510(k) information describes HeadaTerm 2 as indicated for the prophylactic treatment of episodic migraine in patients 18 years of age or older.

What Makes It Stand Out

HeadaTerm 2 is an OTC forehead device with preventive-use labeling for adults with episodic migraine. 

Understanding Relivion MG

Relivion MG is a prescription neuromodulation device for adults with migraine. Relivion describes its therapy as a head-worn device that stimulates the trigeminal and occipital nerves.

How to Compare Relivion Alternatives

Cefaly May Be Relevant to Compare For:

• FDA-cleared acute treatment of migraine and prophylactic treatment of episodic migraine in adults
• Prescription-free access in the U.S., Canada, the EU, and other countries
• Forehead e-TNS targeting the trigeminal nerve pathway
• One-time device ownership with replacement electrode supplies
• HSA/FSA eligibility
• Cefaly Migraine Relief app support where available
• One-on-one coaching and customer support
• Refund-based 90-day satisfaction guarantee for eligible direct purchases

Other Device Factors to Compare:

• Younger patients: Nerivio is indicated for ages 8+, while gammaCore and SAVI Dual materials describe use for ages 12+.
• Cluster headache-related indications: gammaCore materials describe migraine and cluster headache-related indications.
• Upper-arm placement: Nerivio uses an upper-arm wearable format.
• Neck-based placement: gammaCore uses non-invasive vagus nerve stimulation on the side of the neck.
• Magnetic stimulation format: SAVI Dual uses transcranial magnetic stimulation at the back of the head.
• OTC preventive-only comparison: HeadaTerm 2 is an OTC forehead TENS device described for prophylactic treatment of episodic migraine in adults.
• Pricing and refill structure: Current pricing can be verified directly with each manufacturer because device programs, insurance pathways, refill structures, and prescription access models can change.

For people comparing Relivion alternatives, Cefaly offers a distinct combination of prescription-free access, FDA-cleared acute treatment and episodic migraine prevention in adults, forehead e-TNS technology, app support where available, coaching resources, HSA/FSA eligibility, and a refund-based 90-day satisfaction guarantee for eligible direct purchases.

Preguntas frecuentes

What types of alternatives exist for migraine treatment if Relivion is not the right fit?

Several neuromodulation devices use different formats and stimulation targets. Cefaly uses forehead e-TNS targeting the trigeminal nerve pathway. Nerivio uses remote electrical neuromodulation on the upper arm. gammaCore uses non-invasive vagus nerve stimulation on the side of the neck. SAVI Dual uses transcranial magnetic stimulation at the back of the head. HeadaTerm 2 uses a forehead-worn TENS format for preventive use in adults with episodic migraine.

How does external trigeminal nerve stimulation work for acute migraine treatment and preventive use?

External trigeminal nerve stimulation, or e-TNS, delivers gentle electrical impulses through an electrode placed on the forehead, between and just above the eyebrows. Cefaly uses this forehead placement to stimulate branches of the trigeminal nerve pathway. Cefaly's Acute mode is a 60-minute session, while its Prevent mode is a 20-minute daily session for preventive use.

Is Cefaly FDA-cleared?

Yes. Cefaly is FDA-cleared for acute treatment of migraine with or without aura in adults and for prophylactic treatment of episodic migraine in adults. Cefaly is also available without a prescription in the U.S., Canada, the EU, and other countries.

What clinical evidence supports Cefaly?

Cefaly's clinical evidence includes acute-treatment and preventive-use studies. The ACME study reported that 79% of patients experienced significant headache pain reduction after one hour of acute treatment. The PREMICE study reported that 38.1% of patients achieved a 50% or greater reduction in migraine days after three months of compliant preventive use.

Are there serious side effects associated with Cefaly?

Multiple Cefaly clinical studies have reported no serious adverse effects associated with Cefaly treatment. Reported side effects include sleepiness, headache after a session, forehead skin redness, nausea, and forehead skin allergy. These safety statements should remain specific to Cefaly and should not be generalized to all neuromodulation devices.

Who may need individualized clinical guidance before using Cefaly?

Healthcare provider guidance may be important before using Cefaly for people who are pregnant, may become pregnant, are breastfeeding, have an implanted device, have a complex medical history, are changing medications, have never been diagnosed with migraine by a health professional, or are experiencing new, unusual, or changing symptoms. A healthcare provider can help evaluate whether Cefaly is appropriate for a specific person's situation.

Can Cefaly be used for both acute migraine attacks and preventive use?

Yes. Cefaly has two treatment modes. Acute mode is a 60-minute session for migraine attacks, and Prevent mode is a 20-minute daily session for preventive use in episodic migraine. This dual-mode format is one of the main reasons Cefaly is relevant for people comparing Relivion alternatives.

How accessible is Cefaly, and is it HSA/FSA eligible?

Cefaly is available without a prescription in the U.S., Canada, the EU, and other countries. Cefaly is also listed as an HSA/FSA eligible expense. Coverage, reimbursement, and payment rules can vary by plan, so insurance and benefits details should be verified through the relevant plan or benefits administrator.

What is Cefaly’s 90-day satisfaction guarantee?

Cefaly’s return policy states that eligible devices and products purchased fromthe official website may be returned for a refund within 90 calendar days of the product delivery date if the customer is not satisfied. This is a refund policy, not a guarantee of a specific clinical outcome.